Pearlie Chong, M.D.

Pearlie Chong, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Infectious Diseases and Geographic Medicine.

Originally from Johor, Malaysia, Dr. Chong earned her medical degree at the Schulich School of Medicine and Dentistry at Western University in London, Ontario, Canada. She completed internal medicine residency training at Lehigh Valley Health Network in Pennsylvania. She completed advanced training through fellowships in infectious diseases at Georgetown University and transplant infectious diseases at the Mayo Clinic. She later earned a master's degree in clinical research at the University of North Carolina in Chapel Hill.

Certified by the American Board of Internal Medicine in infectious diseases, Dr. Chong joined the UT Southwestern faculty in 2017.

At UT Southwestern, she is the Director of the Stem Cell Transplant and Hematological Malignancies Infectious Diseases Program. 

Dr. Chong is a member of several professional societies. She is a Fellow of the Infectious Diseases Society of America and a member of the American Society of Transplantation.

Dr. Chong's research interests include infections in transplant patients, gut microbiome, gastrointestinal infections, and antibiotic treatment. She has given numerous lectures, as well as published several abstracts and peer-reviewed articles.

Medical School

Western University Canada (2006)

Residency

Lehigh Valley Health Network (2009), Internal Medicine

Fellowship

Georgetown University Hospital (2012), Infectious Diseases

Fellowship

Mayo Clinic (2013), Transplant Infectious Diseases

• Clinical Research Related to Infections in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients
• Study Design and Data Analyses

Featured Publications

Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018.

Suresh S, Upton J, Green M, Pham-Huy A, Posfay-Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, Danziger-Isakov L, Dipchand AI, Hébert D, Kumar D, Morris SK, Nalli N, Ng VL, Nicholas SK, Robinson JL, Solomon M, Tapiero B, Verma A, Walter JE, Allen UD, Pediatr Transplant 2019 Nov 23 7 e13571

Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP, Int. J. Antimicrob. Agents 2019 Sep 54 3 346-350

Norovirus in health care and implications for the immunocompromised host.

Chong PP, Atmar RL, Curr. Opin. Infect. Dis. 2019 Aug 32 4 348-355

The gut microbiota in transplant patients.

Chong PP, Koh AY, Blood Rev. 2019 Aug 100614

Reply to Cheng and Chuang.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clin. Infect. Dis. 2019 Jan

Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP Clin. Infect. Dis. 2018 Sep

Clinical presentation and outcomes of norovirus infection in intestinal allograft compared to native intestine.

Florescu DF, Sonderup JL, Grant W, Chong PP, van Duin D, Kalil AC Transpl Infect Dis 2017 Mar

Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.

Chong PP, van Duin D, Bangdiwala A, Ivanova A, Miller WC, Weber DJ, Gilligan PH, Shea TC Clin Ther 2016 Nov 38 11 2468-2476

Predictors of persistent diarrhea in norovirus enteritis after solid organ transplantation.

Chong PP, van Duin D, Sonderup JL, Grant WJ, Kalil AC, Florescu DF Clin Transplant 2016 Nov 30 11 1488-1493

Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant Recipients.

Hauck CG, Chong PP, Miller MB, Jamieson K, Fine JP, Foster MC, Shea TC, van Duin D Pathog Immun 2016 Fall-Winter 1 2 234-242

• Best (Trainee) Abstract Award
  Thoracic and Critical Care Community of Practice, American Society of Transplantation, World Transplant Congress (2014)
• ID Week Trainee Award Grant
  Infectious Diseases Week (2013)
• Poster of Distinction Award
  American Transplant Congress, Seattle, WA (2013)
• State Champion Team
  American College of Physicians Medical Jeopardy (2009)
• Dean's List for High Academic Achievement
  International Medical University, Malaysia (2003)

• Center for International Blood and Marrow Transplant Research (CIBMTR), Infectious Diseases Working Group (1214)
• Infectious Diseases Society of America (2010)
• Transplant Infectious Diseases Special Interest Group, American Society of Bone Marrow Transplantation (ASBMT) (2014)